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Summary
Objectives: Articular chondrocytes proliferate in monolayer culture, but the expression of the transcription factor SOX9 falls and the ability of
the cells to reform cartilage tissue declines. We have investigated whether retroviral SOX9 expression in extensively passaged human
articular chondrocytes from osteoarthritic (OA) joints enables the cells to regain a cartilage matrix forming phenotype in pellet culture.
Design: Chondrocytes from normal and OA joints were retrovirally transduced with SOX9 and grown to passages 7e10 before being cultured
as pellets of 500,000 cells for 14 days. Pellets were analysed by real time polymerase chain reaction, histology, immunohistochemistry and
1,9-dimethylmethylene blue assay.
Results: Chondrocytes from OA joints displayed higher expression of COL2A1 gene when transduced with SOX9 and cultured as pellets with
10% serum, but glycosaminoglycan (GAG) synthesis was low. Addition of transforming growth factor b-3 and insulin like growth factor-1
increased collagen II expression and GAG synthesis in these SOX9 transduced cell pellets. The cells adopted a rounded morphology and
there was increased deposition of collagen II protein compared to control green ﬂuorescent protein transduced cell pellets. Similar results were
seen with transduced chondrocytes from OA or healthy cartilage. SOX9 transduced human dermal ﬁbroblasts did not show any chondrogenic
response.
Discussion: Transduction with SOX9 primed the passaged articular chondrocytes to regain a chondrocytic phenotype in pellet culture and to
form a cartilaginous matrix, which was enhanced by growth factors. Following transduction, chondrocytes from OA joints showed a similar
capacity for chondrogenic recovery as those from healthy joints, which suggested that OA does not permanently compromise the chondrocyte
phenotype.
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Cartilage
Repair
SocietyArticular chondrocytes are the only cell type found within
articular cartilage. They are responsible for the maintenance
of the tissue’s highly specialised extracellular matrix (ECM),
in which the major components are type II collagen,
aggrecan and hyaluronan. They are embedded in the
ECM and it is established that their rounded morphology
plays a critical role in the regulation of their phenotype1. As a
result of this, the in vitro culture systems under which
articular chondrocytes are grown have a large inﬂuence on
the phenotype they express. In monolayer culture the cells
spread, lose their round morphology and begin to proliferate.
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Received 15 June 2004; revision accepted 5 October 2004.8As the cell numbers expand, they appear ﬁbroblastic and
there is a loss of COL2A1 and aggrecan gene expression,
and a concurrent up-regulation of COL1A1 expression. In
contrast, in suspension culture over non-adherent plastic
surfaces2 or with cells encased in an agarose1,3 or alginate
gel4, there is some retention of the ECM-producing
phenotype and under these conditions the rate of pro-
liferation is very slow.
Many studies have shown that monolayer expanded
cells, which no longer synthesise appreciable cartilage
ECM macromolecules, have a capacity to re-express the
chondrocyte phenotype if they are placed in suspension
culture1. However, with an increasing number of cell
divisions the degree to which the phenotype can be
regained decreases5. This is potentially a major hindrance
to the use of expanded autologous articular chondrocytes in
tissue engineering applications.
To promote the re-expression of the chondrocytic
phenotype after repeated subculture of articular chondro-
cytes, various strategies have been employed. These
include various types of three-dimensional (3D) culture,
the use of media supplements such as hormones,
cytokines, growth factors6, variations in culture oxygen0
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approach, we have investigated the use of gene transfer
and focussed on whether the chondrogenic potential of late
passage human articular chondrocytes (HAC) is irreversibly
lost and if this was affected by the disease status of the
source cells, i.e. if they were from an osteoarthritic (OA)
joint. Previous studies have demonstrated that introducing
genes encoding growth factors known to enhance cartilage
ECM production into chondrocytes can improve cartilage
matrix synthesis by chondrocytes in vitro and in vivo9e11. In
this study we have transduced SOX9, a transcription factor
crucial for the induction and regulation of the chondrocyte
phenotype12, into monolayer expanded HAC from OA joints
using a retroviral vector. We have previously shown that
high efﬁciency retroviral transductions can be achieved by
accelerating the growth of these cells using growth factors
and that SOX9 transduction up-regulates COL2A1 gene
expression in monolayer culture conditions13. In this study
we have investigated if SOX9 transduced human OA
articular chondrocytes after repeated passage can be
induced to re-synthesise a cartilage matrix in pellet culture,
and with growth factors. We also compared the recovery of
phenotype by OA cells following transduction with SOX9
with that of chondrocytes from normal cartilage and
contrasted the results with those from dermal ﬁbroblasts
that were similarly transduced.
Materials and methods
CHONDROCYTE ISOLATION, EXPANSION AND TRANSDUCTION
Human OA articular cartilage was obtained, with informed
consent and local ethical committee approval, following
total knee arthroplasties within 6 h of surgery. Tissue was
taken from areas where the cartilage was largely intact from
joints with clinical conﬁrmation of degenerative OA. Human
articular knee cartilage from non-OA joints was obtained
from above knee amputation resulting from peripheral
vascular disease. Tissue was carefully cut away from the
underlying bone and the human OA or normal chondrocytes
were isolated by a sequential trypsin/collagenase digestion
and then grown as monolayers in Dulbecco’s Modiﬁed
Eagles Medium (DMEM) supplemented with 10% foetal calf
serum (FCS), 100 units/ml penicillin and 100 units/ml
streptomycin (all from Cambrex, Wokingham, UK). For
efﬁcient retroviral transduction, the rate of HAC growth was
increased from passages 2e5 by the addition to the media
of platelet derived growth factor-BB (PDGF-BB, 10 ng/ml),
transforming growth factor (TGF) b-1 (1 ng/ml) and ﬁbro-
blast growth factor-2 (FGF-2, 5 ng/ml) (all from Sigma,
Poole, UK)14. The human OA or normal chondrocytes were
transduced with a RKAT retrovirus containing a bicistroni-
cally expressed complementary deoxyribonucleic acid
(cDNA) encoding human FLAG tagged SOX9 and green
ﬂuorescent protein (GFP), at a titre of 5! 106 as has been
described previously13. These are subsequently referred to
as SOX9 transduced chondrocytes. For control of SOX9
transduction, chondrocytes were transduced with the RKAT
vector containing only GFP and are referred to as GFP
transduced chondrocytes. After repeated transductions
(three times), the cells were at least 90% transduced
(GFP positive). Normal human dermal ﬁbroblasts (NHDF)
(Cambrex, UK) were grown in DMEM, 10% FCS, 100 units/
ml penicillin and 100 units/ml streptomycin and transduced
with the same vectors using the same methodology as for
the articular chondrocytes. The NHDF proliferated at a fargreater rate than the HAC and were transduced without the
growth factors present.
PELLET CULTURE
Transduced and non-transduced normal and OA chon-
drocytes were grown as cell pellets (500,000 cells/pellet) in
DMEM, ITS1C (Sigma, UK), 10 nM dexamethasone
(Sigma, UK) and 25 mg/ml ascorbate 2-phosphate with or
without 10% FCS. Pellets (500,000 cells) were formed with
1 ml medium in 15 ml conical culture tubes spun for 5 min at
160 g (swing out rotor). The wet weight of the cell pellets
was recorded at the end of the culture period. The effect of
growth factors on cell pellet cultures was assessed by
supplementing the medium with 100 ng/ml insulin like
growth factor-1 (IGF-1) and 10 ng/ml TGFb-3 (both from
Sigma, UK). All cultures were grown for 14 days in
a humidiﬁed atmosphere with 5% CO2 and medium was
changed every 2e3 days. NHDF were cultured as pellets
for 14 days in medium containing TGFb-3 and IGF-1.
GENE EXPRESSION ANALYSIS
Total RNA was prepared from monolayer and pellet
cultures using Tri Reagent (Sigma, UK). Pellet cultures
were ground up in the Tri Reagent using Molecular Grinding
Resin (Geno Technology Inc, St Louis, USA). cDNA was
synthesised from 1 mg of total RNA using Moloney murine
leukaemia virus reverse transcriptase and random hexam-
ers (both from Promega, Southampton, UK) in a 25 ml
reaction. Aliquots (1 ml) were ampliﬁed by polymerase chain
reaction (PCR) in 25 ml reaction volumes on an ABI 7700
Sequence Detector or an MJ Research Opticon using
a SYBR Green Core Kit (Eurogentec, Seraing, Belgium)
with gene speciﬁc primers designed using ABI Primer
Express software. Relative expression levels were normal-
ised using glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and calculated using the 2DCt method15. Primer
sequences have been described previously for GAPDH,
aggrecan, collagen I and collagen II16 and SOX913. Other
primer sequences were as follows:
L-SOX5- Forward 5#e3# ATCCCAACTACCATGGCAG-
CT, Reverse 5#e3# TGCAGTTGGAGTGGGC-
CTA,
SOX6- Forward 5#e3# GCAGTGATCAACATGTGG-
CCT, Reverse 5#e3# CGCTGTCCCAGTCAGC-
ATCT,
Deorin- Forward 5#e3# CCTGGACACAACACCAAAA-
AGG, Reverse 5#e3# ATCTGAAGGTGGATGG-
CTGTATCT,
Biglyan- Forward 5#e3# CAGGAGGCGGTCCATAAG-
AAT, Reverse 5#e3# ATGAGGAGGAGGAAC-
AGAACATGT,
Fibromodulin- Forward 5#e3# ACACCGTCCCCGATA-
GCTACT, Reverse 5#e3# GAGGCCAG-
GCCATTGTTG.
All primers were from Invitrogen, Paisley, UK.
BIOCHEMICAL ANALYSIS OF PELLET CULTURES
After culture, pellets were digested overnight in 20 ml of
10 units/ml papain (Sigma, UK), 0.1 M sodium acetate,
2.4 mM ethylenediaminetetraacetic acid, 5 mM L-cysteine,
pH 5.8 at 60(C. DNA content of the papain digest was
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binding with a Hoeffer Dyna Quant 200 ﬂuorometer.
Glycosaminoglycans (GAG) were assayed in the papain
digest using 1,9-dimethylmethylene blue (Aldrich, Poole
UK)17,18 with shark chondroitin sulphate (Sigma, UK) as
standard.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
For histology, pellets were ﬁxed in 4% formaldehyde and
embedded in parafﬁn wax, 5 mm sections were cut and
stained with 0.1% safranin-O. For immunohistochemical
analysis, sections were digested with chondroitinase ABC
and then incubated with antibodies to collagen I (C-18
polyclonal) or collagen II (N-19 polyclonal) (both collagen
antibodies from Santa Cruz Biotechnology, Santa Cruz,
USA). Immunolocalised antigens were visualised with
a biotin conjugated donkey anti-goat secondary antibody
(Santa Cruz Biotechnology) and a streptavidinehorseradish
peroxidase labelling kit using 3,3#-diaminobenzidine (Dako,
Ely, UK). All sections were examined using a Zeiss
Axiovision light microscope.
STATISTICAL ANALYSIS
Statistically signiﬁcant differences between gene expres-
sion values of control and transduced pellet cultures in the
initial serum-containing or serum free cultures were de-
termined using unpaired t tests. Gene expression, wet
weight and GAG content in pellet cultures grown in serum
with growth factors was analysed by univariate analysis of
variance with Tukey post hoc tests using SPSS software.
Results
HAC were isolated from the residual cartilage of OA
joints. The cells were cultured in monolayer and the rate of
cell division was increased by the addition of growth factors
(PDGF-BB, TGFb-1 and FGF-2), which permitted efﬁcient
transduction with retroviral vectors as previously de-
scribed13. At passage 3e4, chondrocytes were transduced
with at least 90% efﬁciency with a bicistronic retroviral
vector containing SOX9 and GFP and control transduced
cells were produced expressing GFP alone using the same
vector. Further culture was without PDGF-BB, TGFb-1 and
FGF-2. In non-transduced OA (or normal) chondrocytes at
passage 7e10, which corresponded to a 1000-fold increase
in cell number, the cells appeared ﬁbroblastic with low
expression of cartilage matrix genes, such as COL2A1
(down 5000-fold), and much increased gene expression of
COL1A1 (up 10-fold). The expression of SOX9 was
reduced to 10% of that of chondrocytes in articular cartilage,
or at ﬁrst passage in monolayer culture. The retroviral
transduction with SOX9 did not result in over-expression,
but restored SOX9 messenger RNA (mRNA) expression to
levels comparable to those seen in freshly isolated
chondrocytes.
The effects of SOX9 transduction on the cells’ potential to
recover a matrix forming chondrocyte phenotype was
investigated in pellet culture, which has previously been
shown to provide chondrogenic signals for differentiating
chondrocytes6. Chondrocytes from late OA knee cartilage
were speciﬁcally used in this study to understand if the
joints pathology was an impediment to their use as
chondrocytes for cell based approaches to cartilage repair.
Chondrocytes were also obtained from non-OA joints. Thisallowed a comparison of the effects of SOX9 transduction
on passaged chondrocytes from both healthy and diseased
tissue. As a guide to chondrogenic phenotype, gene
expression levels of COL1A1 and COL2A1 were determined
by quantitative reverse transcription PCR analysis. Previous
work showed that they provided a sensitive index of the
chondrogenic status of chondrocytes, particularly as the
level of expression of COL2A1 in passaged HAC was
extremely low and less than 0.01% of that of cells in
cartilage13.
EFFECT OF SOX9 TRANSDUCTION ON PASSAGED HUMAN
OA CHONDROCYTES
SOX9 transduction of OA chondrocytes caused a 10-fold
increase in the expression of COL2A1 in monolayer
cultures, compared to GFP transduced OA chondrocyte
cultures [Fig. 1(A, B)]. The expression of COL2A1 in SOX9
transduced cells was further increased 10-fold after 14 days
in pellet culture with serum. Without serum in pellet culture
the increase in COL2A1 expression was smaller [Fig. 1(B)].
There were no effects of SOX9 transduction on COL1A1
gene expression, which remained very high. Without SOX9
transduction the OA chondrocytes showed a very poor
chondrogenic response, as the GFP-OA control transduced
cells showed a decrease in COL2A1 mRNA when grown for
14 days in pellet culture [Fig. 1(A)].
In order to assess ECM production in these cultures, the
wet weight of pellets was compared. Pellets formed from
SOX9 transduced OA chondrocytes after 14 days in serum
free medium had double the wet weight of the GFP
transduced OA chondrocyte pellets. Serum doubled the
weight of SOX9 pellets, but had much less of an effect on
GFP-control pellets [Fig. 1(C)]. FCS (10%) therefore caused
greater stimulation of SOX9 transduced cells and resulted
in a major increase in the accumulation of ECM. The pellets
formed from SOX9 transduced cells were therefore 280% of
the wet weight of pellets formed from GFP transduced OA
chondrocytes.
EFFECT OF IGF-1 AND TGFb-3 ON MATRIX ACCUMULATION IN
SOX9 TRANSDUCED OA CHONDROCYTE PELLET CULTURES
As serum increased matrix accumulation, we also
investigated the effects of IGF-1 and TGFb, which are
known to have anabolic effects on mature chondro-
cytes19,20. TGFb-3 was used in these experiments as it is
active in promoting chondrogenesis in mesenchymal stem
cells21. Pellets of SOX9 transduced OA chondrocytes were
treated in serum-containing medium supplemented with
IGF-1 and TGFb-3 at concentrations that are known to be
effective in stimulating chondrocytes21,22 (Figs. 2 and 3).
IGF-1 had no effect on the wet weight of the SOX9 and GFP
transduced OA cell pellets. Treatment with TGFb-3 alone or
with IGF-1 increased the wet weight of the SOX9 pellets by
61% and 68%, respectively. It also increased the wet weight
of GFP transduced cell pellets by 65% and TGFb-3 together
with IGF-1 increased it by 123% [Fig. 2(A)]. The SOX9
transduced cell pellets with TGFb3 and IGF-1 were thus
33% heavier than GFP transduced controls. GAG analysis
showed that the growth factors caused a large increase in
GAG accumulation [Fig. 2(B)]. In particular, IGF-1 together
with TGFb-3 showed a synergistic effect on GAG/DNA
accumulation in SOX9 transduced OA cell pellets with an
increase to 517% of that in pellets without growth factors.
This was greater than the sum of the effects of TGFb-3 or
IGF-1 alone (increase relative to no-growth factor control
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Fig. 1. (A) Real time PCR analysis of cDNA derived from monolayer
and pellet cultures of untransduced human OA chondrocytes. The
cells were examined between passages 7 and 10 as described in
the text and pellet cultures were conducted for 14 days. Black bars
represent expression levels for comparable monolayer cultures
(nZ 11), grey bars represent pellet cultures grown in serum free
medium (nZ 4) and white bars represent pellet cultures grown in
medium containing 10% FCS (nZ 3). *Z P! 0.05 in pellet vs
monolayer, Student’s unpaired t test. (B) Real time PCR analysis of
cDNA derived from monolayer and pellet cultures of human OA
chondrocytes transduced with SOX9 retrovirus. The black bars
represent expression levels for comparable monolayer cultures
(nZ 9), the grey bars represent pellet cultures grown in serum free
medium (nZ 4) and white bars represent pellet cultures grown in
medium containing 10% FCS (nZ 3). *Z P! 0.01 in pellet vs
monolayer, Student’s unpaired t test. (C) Wet weight of GFP and
SOX9 transduced human OA chondrocytes grown for 14 days as
pellets in the presence or absence of 10% FCS. *Z P! 0.05.pellets of 253% and 132%, respectively). The effects of the
growth factors on GAG accumulation in pellets of GFP
transduced OA cells were much less than on SOX9
transduced OA cells. IGF-1 alone decreased the GAG per
DNA (down 33%); TGFb-3 increased it to 175% of the no-
growth factor control and treatment with both growth factors
gave results similar to those with TGFb-3 alone. The overall
GAG content of SOX9 transduced OA cell pellets after 14
days with both of the growth factors was thus ﬁve times
more than in the pellets formed by GFP transduced OA
cells under the same conditions and 10 times greater than
in the pellets formed by GFP transduced OA cells without
growth factors.
As the ability of chondrocytes to regain a matrix forming
phenotype is reported to decline with passage in culture,
some OA chondrocytes without retroviral transduction were
tested at passage 4 to assess their natural chondrogenic
response under similar culture conditions in pellets. This
was also designed to provide a comparative measure of the
chondrogenic response found in passage 7e10 SOX9
transduced OA chondrocytes. Pellets of passage 4 OA
chondrocytes were formed and cultured for 14 days with or
without TGFb-3 and IGF-1 together. Without growth factors,
the GAG/DNA content was slightly lower than in the late
passage GFP transduced OA cells, but with TGFb-3 and
IGF-1 combined the GAG/DNA content increased to 459%
of the no-growth factor control. This was a larger increase
than that seen in the late passage GFP transduced cells
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Fig. 2. Matrix accumulation in pellet cultures of late passage
(passage 10) human OA chondrocytes transduced with SOX9 or
GFP and early passage (passage 4) untransduced OA chondro-
cytes. Cultures were grown for 14 days in the presence or absence
of growth factors. (A) Pellet wet weight, (B) GAG content of pellet
normalised to DNA content (weight per weight). Pellets were grown
without growth factors (black bars) or in the presence of 100 ng/ml
IGF-1 (dark grey bars), 10 ng/ml TGFb-3 (light grey bars) or both
IGF-1 and TGFb-3 together (white bars). *Z P! 0.05 in growth
factor treatment vs no growth factors, yZ P! 0.05 in SOX9
transduced vs GFP transduced grown under the same conditions.
84 S. R. Tew et al.: SOX9 transduction of OA chondrocytes[Fig. 2(B)]. However, the GAG/DNA was still less than that
shown by SOX9 transduced OA chondrocytes at passage
10 grown under the same conditions.
Histochemical staining of the pellets with safranin-O
showed that those formed from GFP transduced OA cells
[Fig. 3(Aie iv)] had low levels of poorly stained ECM. The
SOX9 transduced OA cell pellets were also poorly stained
in the absence of TGFb-3 [Fig. 3(Av, vi)]. In contrast, they
showed strong safranin-O staining with TGFb-3 alone, or in
combination with IGF-1 [Fig. 3(Avii, viii)]. In addition, the
cells in these pellets had developed a more rounded
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Fig. 3. (A) Histological analysis of SOX9 and GFP transduced late
passage human OA chondrocytes grown as pellets for 14 days.
Parafﬁn wax sections from pellets treated with or without growth
factors were stained with safranin-O. GFP transduced (ieiv) and
SOX9 transduced (veviii) cell pellets were treated with no growth
factor (i and v), 100 ng/ml IGF-1 (ii and vi), 10 ng/ml TGFb-3 (iii and
vii) or both IGF-1 and TGFb-3 together (iv and viii). Scale
barZ 100 mm. (B) Real time PCR analysis of cDNA derived from
growth factor stimulated pellets of late passage OA HAC grown for
14 days. SOX9 transduced and GFP transduced cells were
examined for mRNA levels of COL1A1, COL2A1 and SOX9.
Pellets were grown without growth factors (black bars), in the
presence of 100 ng/ml IGF-1 (dark grey bars), 10 ng/ml TGFb-3
(light grey bars) or both IGF-1 and TGFb-3 together (white bars).
(nZ 3 for all pellets). *Z P! 0.05 in growth factor treatment vs no
growth factors. yZ P! 0.05 in SOX9 transduced vs GFP trans-
duced grown under the same conditions.morphology, characteristic of chondrocytes in cartilage.
Analysis of gene expression showed that in SOX9 OA cell
pellets, COL2A1 gene expression was much higher than in
all control GFP transduced OA cell cultures and it was
further stimulated by TGFb-3, but not by IGF-1 [Fig. 3(B)].
SOX9 gene expression was at high levels in all of the SOX9
transduced cell cultures due to their transduction and it was
unaltered by the growth factors. Both SOX9 transduced and
GFP transduced OA cell pellets had similar high levels of
COL1A1 mRNA and TGFb-3 increased this expression.
These results together with those of wet weight analysis
and total GAG showed that the growth factors, chieﬂy
TGFb-3, greatly increased the chondrocytes’ matrix forming
phenotype.
EXPRESSION OF L-SOX5, SOX6 AND PROTEOGLYCAN GENES
IN SOX9 TRANSDUCED OA CHONDROCYTE PELLET
CULTURES TREATED WITH GROWTH FACTORS
To further characterise the effect of SOX9 transduction
and growth factor stimulation (GFS) on OA chondrocyte
pellet cultures we investigated the expression of L-SOX5
and SOX6 genes and also proteoglycans known to form
part of the cartilage ECM (Fig. 4). L-SOX5 and SOX6 are
homologous proteins which form either homo- or hetero-
dimers and which bind to a chondrocyte speciﬁc enhancer
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Fig. 4. Real time PCR analysis of cDNA derived from growth factor
stimulated pellets of late passage human OA chondrocytes grown
for 14 days. SOX9 and GFP transduced cells were examined for
mRNA levels of L-SOX5, SOX6, aggrecan, decorin, biglycan, and
ﬁbromodulin as indicated. GFS indicates treatment with 100 ng/ml
IGF-1 and 10 ng/ml TGFb-3 together. *Z P! 0.05 in growth factor
treatment vs no growth factors. nZ 3 in all instances except
aggrecan and SOX6 analysis of GFP no-growth factor pellets
(nZ 7) and SOX9 no-growth factor pellets (nZ 5) **Z P! 0.05
in SOX9 transduced vs GFP transduced grown under the same
conditions.
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Fig. 5. Immunohistochemical analysis of 14-dayOA chondrocyte pellet cultures grown in the presence of 100 ng/ml IGF-1 and 10 ng/ml TGFb-3.
Chondrocytes were transduced with GFP (A, C) or SOX9 (B, D). Sections were labelled with antibodies to collagen II (A and B) or collagen I (C
and D). GFP transduced sections labelled using no primary antibody (E) or control IgG (F) are shown as examples of controls. Scale
barsZ 100 mm.region within the ﬁrst intron of the type II collagen gene in
concert with SOX923. Aggrecan is the major proteoglycan
component of the ECM and decorin, biglycan and ﬁbromo-
dulin are small leucine rich proteoglycans that are all found
within cartilage. Analysis of pellets showed that the
presence of the growth factors decreased the expression
of L-SOX5, SOX6 and decorin and this was independent of
SOX9 transduction (Fig. 4). Biglycan expression was
unchanged under any conditions and ﬁbromodulin was
up-regulated in SOX9 transduced cell cultures, but
was unaffected by the growth factors. Aggrecan mRNA
was higher in SOX9 transduced OA cells, but growth factors
decreased its expression.
COLLAGEN DEPOSITION IN SOX9 TRANSDUCED OA
CHONDROCYTE PELLET CULTURES TREATED
WITH GROWTH FACTORS
To examine whether increased levels of COL2A1 gene
expression translated into greater accumulation of collagentype II protein, SOX9 transduced OA chondrocyte pellets
grown with TGFb-3 and IGF-1 were immunostained with
antibodies to collagen type II and collagen type I (Fig. 5).
Pellets of SOX9 transduced OA cells were strongly labelled
with anti-collagen type II, which was distributed uniformly
throughout the pellet [Fig. 5(B)]. In contrast, in these pellets
anti-collagen type I immunostaining was faint, but it was
also evenly distributed [Fig. 5(D)]. In GFP transduced
pellets, collagen type II was localised to an area just
beneath the surface of the pellet, but there was much less
present in the centre of the pellet [Fig. 5(A)]. Collagen type I
was localised at the surface of the GFP transduced cell
pellets corresponding to the collagen type II negative ‘‘rim’’
[Fig. 5(C)]. Primary antibody and non-speciﬁc IgG controls
showed no staining [Fig. 5(E and F), respectively].
Therefore, SOX9 transduction of OA chondrocytes gave
a more uniform collagenous network in pellet culture, which
stained strongly for collagen type II and this may reﬂect
a more uniform differentiated cell population throughout the
pellet.
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e
n
e
 
e
x
p
r
e
s
s
i
o
n
 
n
o
r
m
a
l
i
s
e
d
u
s
i
n
g
 
G
A
P
D
H
G
e
n
e
 
e
x
p
r
e
s
s
i
o
n
 
n
o
r
m
a
l
i
s
e
d
u
s
i
n
g
 
G
A
P
D
H
COL1        COL2          SOX9
COL1 COL2 SOX9
GFP SOX9_GFP
C
o
l
l
a
g
e
n
 
T
y
p
e
 
I
I
C
o
l
l
a
g
e
n
 
T
y
p
e
 
I
A B
C D
GFP SOX9_GFP
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in Fig. 3 and the data are comparable to the OA chondrocyte expression levels shown in Fig. 3(B). (B) Immunohistochemical analysis of
collagen type II and type I in 14-day normal chondrocyte pellet cultures, either GFP transduced or SOX9 transduced as indicated. Pellets were
grown in the presence of 100 ng/ml IGF-1 and 10 ng/ml TGFb-3. Scale barZ 100 mm. (C) Real time PCR analysis of 14-day NHDF pellet
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10 ng/ml TGFb-3. Scale barZ 100 mm.SOX9 TRANSDUCTION AND PELLET CULTURE OF NORMAL
HAC AND PRIMARY HUMAN SKIN FIBROBLASTS
In order to understand if OA disease status was a factor
limiting the ability of articular chondrocytes to regain a matrix
forming phenotype, experiments were set up to compare
chondrocytes from OA and non-OA healthy joints. Chon-
drocytes from normal articular cartilage in non-OA joints
were transduced with SOX9 and grown to late passage
using the same technique as that used for the OA
chondrocytes. Pellet cultures grown in combined TGFb-3
and IGF-1 medium showed the same major increases in
matrix deposition in pellet culture as those seen with the OA
cells. Gene expression analysis showed similar stimulation
of COL2A1 gene (10 fold) by SOX9 as that seen in the OA
cells [Fig. 6(A)]. As with the OA cells, the increased levels of
SOX9 affected COL2A1 but not COL1A1 expression, which
remained unchanged. It should be noted that COL2A1
expression was 30 times higher in GFP transduced normal
chondrocyte pellets than in those formed from GFP trans-
duced OA chondrocytes at similar passage [comparing
Fig. 6(A) to Fig. 3(B)]. The expression of COL1A1 was also
high and of similar level to that found in pellets formed
from SOX9 or GFP transduced OA chondrocytes.Immunohistochemistry for collagen type II and collagen
type I in SOX9 and GFP transduced normal chondrocyte
cell pellets showed a similar distribution to that in trans-
duced OA chondrocyte pellets [Fig. 6(B)]. SOX9 trans-
duction therefore enhanced the chondrogenic response to
pellet culture and growth factors of both OA and normal
chondrocytes. These results showed that the response of
passaged articular chondrocytes to retroviral transduction
with SOX9 was similar whether they were from an OA joint,
or from a normal healthy joint of comparable age.
To determine whether the effects of SOX9 transduction
were speciﬁc to chondrocytes, human dermal ﬁbro-
blasts were transduced with SOX9 after passage in culture
and were grown as pellets with TGFb-3 and IGF-1. Gene
expression analysis of these pellets showed that there was
an increase in COL2A1 gene expression in SOX9 trans-
duced ﬁbroblasts compared to GFP transduced cells
[Fig. 6(C)], but the level remained more than 1000-fold less
than in SOX9 transduced OA chondrocytes. Histological
analysis of the pellets showed that SOX9 transduction did
not result in pellet enlargement, cell rounding or deposition
of GAG-rich ECM [Fig. 6(D)]. Therefore, SOX9 transduction
was unable to cause the chondrogenic differentiation, or
87Osteoarthritis and Cartilage Vol. 13, No. 1matrix forming phenotype in primary human dermal
ﬁbroblasts.
Discussion
Articular chondrocytes lose their phenotype when iso-
lated and grown in monolayer culture24. Whilst it has been
shown that the phenotype can be regained during early
passage by growing the cells in 3D culture systems, this
ability was reported to diminish in late passage cells5. It has
also been shown that the expression of many cartilage
matrix genes, such as collagen type II, is reduced in
monolayer culture and that the transcription factor SOX9 is
also down-regulated2,25e27. In a previous study we dem-
onstrated that retroviral expression of SOX9 in human OA
articular chondrocytes leads to an up-regulation in expres-
sion of collagen type II gene and protein13. These data
corresponded well with the results of transient SOX9
transduction in murine primary cells, and in a number of
chondrocytic cell lines23,26. However, despite the SOX9
expression, the collagen II gene expression levels in
monolayer cultures were still several orders of magnitude
less than those seen in chondrocytes in vivo. In this study
we investigated whether combining SOX9 transduction with
a 3D culture was able to renew the capacity of late passage
human OA articular chondrocytes to form cartilage matrix.
Furthermore, we tested if there was a difference in the
response of OA and normal chondrocytes under these
culture conditions.
Comparing the gene expression of cartilage matrix genes
in chondrocytes with or without SOX9 transduction and in
different culture conditions has enabled us to describe
a number of factors which contribute towards the de-
velopment of a stronger matrix forming chondrocyte
phenotype in these late passage cells. Without SOX9
transduction, the OA chondrocytes transduced with GFP
actually displayed lower levels of collagen II mRNA when
placed in pellet culture and there was no increase in SOX9
expression. The endogenous chondrogenic response of
these passaged OA cells was therefore very low. The exact
mechanism by which chondrocytes respond to pellet culture
is unclear, but it may involve increased cellecell interac-
tions and an improved environment for localised paracrine
signalling. SOX9 transduction clearly increased the chon-
drogenic response of these passaged OA chondrocytes in
pellet culture, but without anabolic growth factors present,
the mechanisms active in pellet culture appeared only able
to support a partial recovery of the chondrocyte phenotype.
The addition of serum was able to signiﬁcantly increase the
wet weight of the SOX9 transduced cell pellets as well as
promote collagen II gene expression and GAG accumula-
tion. This effect of serum is likely to be due to the growth
factors it contains. However, other components in serum,
such as ﬁbronectin, which has demonstrated importance in
celleECM signalling during early stages of chondrogene-
sis28, may also be inﬂuential. The effect of additional growth
factors, IGF-1 and TGFb-3, was also potentiated by SOX9
transduction. When the growth factors were added to-
gether, the pellets formed with SOX9 transduced OA cells
differed in a number of ways from those transduced with
GFP alone. Firstly, SOX9 transduced cells produced the
heaviest pellets with the highest level of COL2A1 expres-
sion and GAG content. In addition, collagen type II
immunostained uniformly throughout the SOX9 pellets.
Therefore, SOX9 transduction potentiated a more robust
chondrogenic response throughout the pellet, whereas thecontrol GFP transduced cell pellets showed a less complete
and patchy chondrogenic response. Finally, the effects of
the growth factors on GAG accumulation in the pellets were
only synergistic with SOX9 transduced cells. It is clear that
SOX9 enhances the chondrocytes’ ability to respond to
these growth factors, to serum and to pellet culture,
although the underlying mechanisms are as yet unclear.
SOX9 is known to regulate the expression of genes such as
collagen types II26, XI29, and IX30 and aggrecan31, which all
encode important cartilage matrix proteins. There is
evidence that cellular attachment to collagen type II is able
to modulate TGFb signalling in articular chondrocytes32.
Furthermore, chondrocytes cultured as chondrons, with
their pericellular matrix still intact, show signiﬁcant differ-
ences in their reactions to culture stimuli33e35. The
formation of a pericellular matrix facilitated in pellet culture
may be necessary for efﬁcient matrix signalling to chon-
drocytes and for modulating the transduction of those
signals into changes in gene expression. There is evidence
that SOX9 has a role and inﬂuence on bone morphogenetic
protein and sonic hedgehog signalling in mesenchymal
progenitor cells36,37 and the increased expression of SOX9
may thus change the way in which the chondrocytes
transduce the growth factor and other matrix signals.
It was a notable feature of these passaged OA
chondrocytes that the high expression of COL1A1 gene
was not accompanied by high collagen I protein expression
in monolayer or in pellet culture. Collagen I immunostaining
was weak, but was similar in SOX9 and GFP transduced
cell pellets. These results suggest that collagen type I
protein expression is not directly correlated with the level of
COL1A1 mRNA and that there is major control of collagen
type I translation to produce protein. The result also shows
that SOX9 does not play a role in controlling the gene
expression, protein synthesis or secretion of collagen type I.
In OA cartilage, chondrocytes express higher levels of
COL1A1 in vivo than chondrocytes from normal cartilage38,
but the level of COL1A1 mRNA increases in all chondro-
cytes, when isolated and grown in monolayer culture. There
is the possibility that the techniques used would detect
COL1A1 antisense in the PCR reactions, which has been
detected in chick embryo chondrocytes39. However, what-
ever the mechanism for control of type I collagen protein
expression, it is clear that it remains low in these passaged
OA cells in pellet culture.
SOX9 interacts with cartilage speciﬁc promoters in
conjunction with a number of transcriptional co-activators,
which include the CREB and its paralog p30040 as well as
L-SOX5 and SOX623. We investigated the expression of L-
SOX5 and SOX6 in 14-day SOX9 transduced cell pellets
cultured with or without TGFb-3 and IGF-1 and found that
not only was their expression unaffected by SOX9 trans-
duction, but that their expression levels were reduced upon
culturing in the presence of the growth factors. This was
a surprise, as these two genes have been shown to co-
operate with SOX9 at the collagen type II speciﬁc enhancer
within the ﬁrst intron23, and to be essential factors for
cartilage formation during development41. There is also
clear evidence that chondrocyte progression through
endochondral ossiﬁcation is adversely affected as the
expression of these SOX genes is lost in heterozygous
and null mouse embryos42. In the SOX9 transduced cell
pellet system, however, in spite of the reduced levels of
L-SOX5 and SOX6 there was a marked increase in
proteoglycan synthesis and a small increase in COL2A1
expression and increased collagen type II immunostaining.
These results suggest that the levels of L-SOX5 and SOX6
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act in promoting/enhancing matrix protein expression once
the level of SOX9 is increased.
To further characterise the phenotype of the SOX9
transduced OA cells in pellet culture, gene expression
analysis of four proteoglycan genes present in cartilage was
conducted. Aggrecan gene expression was increased by
SOX9 transduction and this correlated with increases in
GAG content of the pellets. This result adds to the evidence
that SOX9 is involved in the transcriptional regulation of the
aggrecan gene31. Of the three small leucine rich proteogly-
cans examined, only ﬁbromodulin mRNA was up-regulated
by SOX9 expression and as such may represent a novel
target for SOX9 transcriptional regulation. Biglycan expres-
sion was unaffected by any of the culture conditions, whilst
decorin expression was reduced in the presence of the two
growth factors. It is interesting that decorin should be down-
regulated in the presence of TGFb-3, as a previous study
has shown that TGFb-1 up-regulates decorin in canine
cartilage explant culture43. These data, along with the high
levels of COL1A1 seen in all pellet cultures examined,
suggest that the SOX9 transduced cells after 14 days of
pellet culture still have many differences in expression from
mature chondrocytes in cartilage.
This study shows that passaged human OA chondro-
cytes even after extensive subculture retain an ability to
respond to SOX9 transduction, whereas dermal ﬁbroblasts
transduced with SOX9 display no signs of chondrogenesis
even when grown in pellet culture. It was previously shown
that SOX9 expression did not induce COL2A1 expression in
murine non-chondrocytic cell lines grown in monolayer
culture23. This shows that SOX9 alone cannot confer
a chondrogenic status and suggests that passaged
chondrocytes, even though they appear ﬁbroblastic and
down-regulate many matrix genes, retained elements of
their chondrocyte origin. These data show that SOX9
provides a priming role to passaged chondrocytes, enabling
them to respond to chondrogenic stimuli and re-initiate
a matrix forming phenotype. The loss of SOX9 expression
by the chondrocytes during monolayer culture appears to
lead to a progressive decline in the ability of the cells to re-
express their phenotype when placed in pellet cultures.
Because SOX9 expression declines gradually during
passages27 there may be sufﬁcient production of the
protein during early stages of chondrocyte culture (!4
passages) to support a response to chondrogenic culture
conditions. However, in the cells that we have examined in
this study (O7 passages) the expression of SOX9 reached
a level 10-fold lower than that in differentiated chondro-
cytes. This appears to be too low to allow the re-initiation of
a chondrogenic phenotype over the 14-day culture period.
Retroviral expression of SOX9 raised the mRNA level to
that seen in chondrocytes in vivo and this facilitated the re-
expression of the chondrocyte phenotype when placed in
pellet culture with growth factors (IGF-1 and TGFb-3). It
remains to be determined what physiological signals initiate
and maintain SOX9 expression.
Finally, we have shown that the responses of normal
human chondrocytes in these experiments were the same
as the responses of chondrocytes from OA joints following
SOX9 transduction. The initial status of the OA chondro-
cytes appeared therefore not to have resulted in permanent
differences in the expanded progeny. This is a very
important concept, which implies that the potential of cells
from OA joints may not be permanently compromised by
their pathological background and given appropriate signals
they may regain a chondrogenic phenotype.Acknowledgements
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